➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Boehringer Ingelheim
Medtronic
McKinsey
Johnson and Johnson

Last Updated: June 20, 2021

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for lofexidine hydrochloride


Email this page to a colleague

« Back to Dashboard

Bulk Pharmaceutical API Sources for lofexidine hydrochloride

Vendor Vendor Homepage Vendor Sku API Url
NIH Clinical Collection   Try Before You Buy SAM001246820   Try Before You Buy
NovoSeek   Try Before You Buy 30667   Try Before You Buy
ISpharm   Try Before You Buy I14-1979   Try Before You Buy
MolPort   Try Before You Buy MolPort-005-940-373   Try Before You Buy
ABI Chem   Try Before You Buy AC1L1K1A   Try Before You Buy
ChemMol   Try Before You Buy 44005983   Try Before You Buy
>Vendor >Vendor Homepage >Vendor Sku >API Url

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
AstraZeneca
Moodys
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.